Filing
1st Quarter - Report
Lobbying activity
1
Advocacy related to NIH and ARPA-H funding for treatment of ALS, Parkinsons disease, cancer, and schizophrenia.
Advocacy related to NIH and ARPA-H funding for treatment of ALS, Parkinsons disease, cancer, and schizophrenia.